Literature DB >> 21918191

Ecto-5'-nucleotidase (CD73) decreases mortality and organ injury in sepsis.

György Haskó1, Balázs Csóka, Balázs Koscsó, Rachna Chandra, Pál Pacher, Linda F Thompson, Edwin A Deitch, Zoltán Spolarics, László Virág, Pál Gergely, Rolando H Rolandelli, Zoltán H Németh.   

Abstract

The extracellular concentrations of adenosine are increased during sepsis, and adenosine receptors regulate the host's response to sepsis. In this study, we investigated the role of the adenosine-generating ectoenzyme, ecto-5'-nucleotidase (CD73), in regulating immune and organ function during sepsis. Polymicrobial sepsis was induced by subjecting CD73 knockout (KO) and wild type (WT) mice to cecal ligation and puncture. CD73 KO mice showed increased mortality in comparison with WT mice, which was associated with increased bacterial counts and elevated inflammatory cytokine and chemokine concentrations in the blood and peritoneum. CD73 deficiency promoted lung injury, as indicated by increased myeloperoxidase activity and neutrophil infiltration, and elevated pulmonary cytokine levels. CD73 KO mice had increased apoptosis in the thymus, as evidenced by increased cleavage of caspase-3 and poly(ADP-ribose) polymerase and increased activation of NF-κB. Septic CD73 KO mice had higher blood urea nitrogen levels and increased cytokine levels in the kidney, indicating increased renal dysfunction. The increased kidney injury of CD73 KO mice was associated with augmented activation of p38 MAPK and decreased phosphorylation of Akt. Pharmacological inactivation of CD73 in WT mice using α, β-methylene ADP augmented cytokine levels in the blood and peritoneal lavage fluid. These findings suggest that CD73-derived adenosine may be beneficial in sepsis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21918191      PMCID: PMC3387540          DOI: 10.4049/jimmunol.1003379

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  78 in total

1.  Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis.

Authors:  R F Guo; M Huber-Lang; X Wang; V Sarma; V A Padgaonkar; R A Craig; N C Riedemann; S D McClintock; T Hlaing; M M Shi; P A Ward
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

2.  Immune suppression in polymicrobial sepsis: differential regulation of Th1 and Th2 responses by p38 MAPK.

Authors:  G Y Song; C S Chung; I H Chaudry; A Ayala
Journal:  J Surg Res       Date:  2000-06-15       Impact factor: 2.192

3.  Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms.

Authors:  G Haskó; D G Kuhel; J F Chen; M A Schwarzschild; E A Deitch; J G Mabley; A Marton; C Szabó
Journal:  FASEB J       Date:  2000-10       Impact factor: 5.191

4.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

5.  Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis.

Authors:  R Nevière; H Fauvel; C Chopin; P Formstecher; P Marchetti
Journal:  Am J Respir Crit Care Med       Date:  2001-01       Impact factor: 21.405

Review 6.  Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug.

Authors:  Andreas Oberholzer; Caroline Oberholzer; Lyle L Moldawer
Journal:  Crit Care Med       Date:  2002-01       Impact factor: 7.598

7.  Transcription factor NF kappa B expression and postsurgical organ dysfunction.

Authors:  S Foulds; C Galustian; A O Mansfield; M Schachter
Journal:  Ann Surg       Date:  2001-01       Impact factor: 12.969

8.  High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock.

Authors:  C Martin; M Leone; X Viviand; M L Ayem; R Guieu
Journal:  Crit Care Med       Date:  2000-09       Impact factor: 7.598

Review 9.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.

Authors:  B B Fredholm; A P IJzerman; K A Jacobson; K N Klotz; J Linden
Journal:  Pharmacol Rev       Date:  2001-12       Impact factor: 18.923

10.  Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction.

Authors:  M R Blackburn; J B Volmer; J L Thrasher; H Zhong; J R Crosby; J J Lee; R E Kellems
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

View more
  52 in total

Review 1.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

2.  CD73-generated adenosine is critical for immune regulation during Toxoplasma gondii infection.

Authors:  Deeqa A Mahamed; Leon E Toussaint; Margaret S Bynoe
Journal:  Infect Immun       Date:  2014-12-01       Impact factor: 3.441

3.  Intestinal immunopathology is associated with decreased CD73-generated adenosine during lethal infection.

Authors:  V Francois; H Shehade; V Acolty; N Preyat; P Delrée; M Moser; G Oldenhove
Journal:  Mucosal Immunol       Date:  2014-11-12       Impact factor: 7.313

4.  Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing.

Authors:  Balázs Csóka; Zoltán H Németh; Gábor Törő; Marco Idzko; Andreas Zech; Balázs Koscsó; Zoltán Spolarics; Luca Antonioli; Karolina Cseri; Katalin Erdélyi; Pál Pacher; György Haskó
Journal:  FASEB J       Date:  2015-06-09       Impact factor: 5.191

Review 5.  P2X4 receptors, immunity, and sepsis.

Authors:  Luca Antonioli; Corrado Blandizzi; Matteo Fornai; Pál Pacher; H Thomas Lee; György Haskó
Journal:  Curr Opin Pharmacol       Date:  2019-03-25       Impact factor: 5.547

6.  CD73 regulates anti-inflammatory signaling between apoptotic cells and endotoxin-conditioned tissue macrophages.

Authors:  Patrick S Murphy; Jing Wang; Samir P Bhagwat; Joshua C Munger; William J Janssen; Terry W Wright; Michael R Elliott
Journal:  Cell Death Differ       Date:  2017-01-06       Impact factor: 15.828

Review 7.  Targeting Hypoxia Signaling for Perioperative Organ Injury.

Authors:  Xiaoyi Yuan; Jae W Lee; Jessica L Bowser; Viola Neudecker; Srikanth Sridhar; Holger K Eltzschig
Journal:  Anesth Analg       Date:  2018-01       Impact factor: 5.108

8.  Proximal Tubule CD73 Is Critical in Renal Ischemia-Reperfusion Injury Protection.

Authors:  Sun-Sang J Sung; Li Li; Liping Huang; Jessica Lawler; Hong Ye; Diane L Rosin; Issah S Vincent; Thu H Le; Jing Yu; Nicole Görldt; Jürgen Schrader; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2016-09-14       Impact factor: 10.121

Review 9.  Adenosine receptors as drug targets--what are the challenges?

Authors:  Jiang-Fan Chen; Holger K Eltzschig; Bertil B Fredholm
Journal:  Nat Rev Drug Discov       Date:  2013-04       Impact factor: 84.694

10.  Ecto-5'-Nucleotidase (CD73) Deficiency in Mycobacterium tuberculosis-Infected Mice Enhances Neutrophil Recruitment.

Authors:  Laetitia Petit-Jentreau; Grégory Jouvion; Patricia Charles; Laleh Majlessi; Brigitte Gicquel; Ludovic Tailleux
Journal:  Infect Immun       Date:  2015-07-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.